1. Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open‐label, dose‐escalation Study. Issue 1 (1st November 2018) Authors: Chen, Qiuyan; Tang, Linquan; Liu, Na; Han, Feng; Guo, Ling; Guo, Shanshan; Wang, Jianwei; Liu, Huai; Ye, Yanfang; Zhang, Lu; Liu, Liting; Wang, Pan; Li, Yingqin; He, Qingmei; Yang, Xiaoqun; Tang, Qingnan; Li, Yang; Liang, YuJing; Sun, XueSong; Xie, Chuanmiao Journal: Cancer communications Issue: Volume 38:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗